When was Lunit founded?

Lunit was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is Lunit located?

Lunit is headquartered in Seoul, South Korea. It is registered at 4F–9F, 374 Gangnam-daero, Gangnam-gu, Seoul (Yeoksam-dong, K-Square Gangnam II).

How many employees does Lunit have?

As of Jul 31, 2026, the latest employee count at Lunit is 331.

Is Lunit a funded company?

Lunit is a funded company, having raised a total of $135M across 7 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2014.

When was the latest funding round of Lunit?

Lunit's latest funding was a $***** Series C round on Nov 25, 2021, with participation from 5 investors.

What is the annual revenue of Lunit?

Annual revenue of Lunit is between $50M and $100M as on Dec 31, 2025

Where does Lunit rank among its competitors?

Lunit ranks 4th amongst 138 active competitors, of which 47 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Harbinger Health, which secured $100M in Apr, 2026.

Who are the top competitors of Lunit?

Lunit's top competitors include PAIGE, Ibex and Aignostics. Among them, Harbinger Health secured the most recent funding round in April, 2026.

Lunit - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of medical software for cancer screening and oncology diagnostics. This technology utilizes artificial intelligence to analyze medical imaging and pathology data. The software assists clinicians in identifying potential malignancies in chest and breast scans. Additionally, the platform provides tools for biomarker analysis and tissue quantification to support treatment decisions in oncology. These solutions integrate into clinical workflows to facilitate the interpretation of complex diagnostic data.

Website: www.lunit.io/en/
Social
Email ID: *****@lunit.io, *****@lunit.io, *****@lunit.io
Registered Address: 4F–9F, 374 Gangnam-daero, Gangnam-gu, Seoul (Yeoksam-dong, K-Square Gangnam II)

Key Metrics

Founded Year

2013

Location

Seoul, South Korea

Stage

Public

Total Funding

$135M in 7 rounds

Latest Funding Round

Series C, Nov 25, 2021, $*****

Investors

InterVest & 26 more

Ranked

4^th among 138 active competitors

Annual Revenue

$50M - $100M as on Dec 31, 2025

Employee Count

331 as on Jul 31, 2026

Investment & Acquisitions

Volpara Health

Similar Companies

OpenEvidence & 2940 more

Exit Details

Public

View Lunit's full profile

Lunit is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Lunit Co., Ltd. CIN: 314-86-50626 , South Korea, Active	Aug 23, 2013	$50M - $100M (As on Dec 31, 2025)	-	-

Lunit got listed on Jul 21, 2022.

Click here to take a look at Lunit's IPO in detail

Lunit has raised a total funding of $135M over 7 rounds. Its first funding round was on 2014. Its latest funding round was a Series C round on Nov 25, 2021 for $*****. 5 investors participated in its latest round. Lunit has 27 institutional investors.

Here is the list of recent funding rounds of Lunit:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 25, 2021	8327959	Series C	1413407	5143807	6066116	8379158
Jul 19, 2021	1619987	Series C	4890321	4145849	4029857	Shinhan Financial Group & 5 more
Jan 06, 2020	6150018	Series C	1217031	9281653	Shinhan Investment Corp	Legend Capital & 5 more

Access funding benchmarks and valuations. Sign up today!

View details of Lunit's funding rounds and investors

The founders of Lunit is Anthony Paek. Brandon B Suh is the CEO of Lunit.

Here are the details of Lunit's key team members:

Anthony Paek: Co-Founder of Lunit. They serve on the board of 1 company.
Contact Info: 1 email address

Lunit's Board of Directors

Lunit's board has 6 active members. Anthony Paek and Brandon Beomseok Suh are part of team and Joonpyo Lee, Garheng Kong, Wonbok Lee and Zeongwon Kim are independent board members.

Here is the list of Lunit's board of directors:

Name	Type	Representing	Status	Duration
Anthony Paek	Team	-	Current	-
klcgqas	Team	-	Current	9y 6m
Joonpyo Lee	Independent board member	-	Current	-
{icvswo	Independent board member	-	Current	8y 6m
vuztvuv	Independent board member	-	Current	2y 3m
omqxeul	Independent board member	-	Current	3y 4m

View details of Lunit's Founder profiles and Board Members

Lunit's employee count trend

Lunit has 331 employees as of Jul 26. Here is Lunit's employee count trend over the years:

Uncover Lunit's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Lunit include PAIGE, Ibex and Aignostics. Here is the list of Top 10 competitors of Lunit, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PAIGE 2018, New York City (United States), Acquired	Developer of AI applications and foundation models for cancer diagnostics	$241M	Goldman Sachs, Casdin Capital & 9 others	71/100
2nd	Ibex 2016, Tel Aviv (Israel), Series C	Provider of AI-powered diagnostic solutions for pathology	$114M	83NORTH, Kreos Capital & 6 others	68/100
3rd	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Wellington Partners Venture Capital, Boehringer Ingelheim Venture Fund ... & 9 others	64/100
4th	Lunit 2013, Seoul (South Korea), Public	Developer of medical software for cancer screening and oncology diagnostics	$135M	Deep Learning, Tybourne Capital Management ... & 25 others	71/100
5th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	MassMutual, Accomplice & 12 others	61/100
6th	Valar Labs 2021, Palo Alto (United States), Series A	Developer of AI diagnostics for predicting cancer treatment response likelihood	$26.1M	Andreessen Horowitz, DCVC & 18 others	60/100
7th	Enspectra Health 2014, Mountain View (United States), Series A	Developer of medical devices for tissue imagining and cancer detection	$15.5M	Foothill Ventures, Tao Capital Partners & 6 others	59/100
8th	Proscia 2014, Philadelphia (United States), Series C	Provider of an AI and cloud-based digital pathology solution for cancer diagnosis	$129M	Triangle Peak Partners, Insight Partners ... & 22 others	59/100
9th	Harbinger Health 2008, Cambridge (United States), Series B	AI-based cancer detection tool for providers	$290M	Flagship Pioneering, M&G & 4 others	57/100
10th	Cyted 2018, Cambridge (United Kingdom), Series B	Leader in non-endoscopic diagnostics for digestive health, enabling early disease detection and access to care for all	$50.4M	Advent Life Sciences, EQT & 3 others	57/100